ATE88097T1 - Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut. - Google Patents

Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.

Info

Publication number
ATE88097T1
ATE88097T1 AT85114425T AT85114425T ATE88097T1 AT E88097 T1 ATE88097 T1 AT E88097T1 AT 85114425 T AT85114425 T AT 85114425T AT 85114425 T AT85114425 T AT 85114425T AT E88097 T1 ATE88097 T1 AT E88097T1
Authority
AT
Austria
Prior art keywords
blood
patient
components
immunosupressive
removal
Prior art date
Application number
AT85114425T
Other languages
English (en)
Inventor
M Rigdon Lentz
Original Assignee
Anisa Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anisa Medical Inc filed Critical Anisa Medical Inc
Application granted granted Critical
Publication of ATE88097T1 publication Critical patent/ATE88097T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3403—Regulation parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342—Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3441—Substitution rate control as a function of the ultrafiltration rate
    • A61M1/3448—Substitution rate control as a function of the ultrafiltration rate by mechanically linked pumps in both ultra-filtrate and substitution flow line
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3331—Pressure; Flow
    • A61M2205/3344—Measuring or controlling pressure at the body treatment site

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
AT85114425T 1984-11-16 1985-11-13 Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut. ATE88097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/671,990 US4708713A (en) 1984-11-16 1984-11-16 Method and system for removing immunosuppressive components from the blood of mammals
EP85114425A EP0184040B1 (de) 1984-11-16 1985-11-13 Verfahren und System zur Entfernung von immunosuppressiven Bestandteilen aus Säugetierblut

Publications (1)

Publication Number Publication Date
ATE88097T1 true ATE88097T1 (de) 1993-04-15

Family

ID=24696702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85114425T ATE88097T1 (de) 1984-11-16 1985-11-13 Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.

Country Status (10)

Country Link
US (1) US4708713A (de)
EP (1) EP0184040B1 (de)
JP (1) JPS61172563A (de)
AT (1) ATE88097T1 (de)
AU (1) AU596567B2 (de)
CA (1) CA1262681A (de)
DE (1) DE3587266T2 (de)
IL (1) IL77062A0 (de)
MX (1) MX168132B (de)
ZA (1) ZA858676B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898675A (en) * 1983-08-15 1990-02-06 Lavender Ardis R System and method for continuously fractionating blood in situ
US4767399A (en) * 1986-12-05 1988-08-30 Fisher Scientific Group Inc. Dba Imed Corporation Volumetric fluid withdrawal system
IT1217332B (it) * 1988-02-02 1990-03-22 Dideco Spa Procedimento per il trattamento extracorporeo di liquido ascitico
US4964848A (en) * 1988-06-27 1990-10-23 Bloom Philip M Treatment of multiple sclerosis with lymphocytapheresis and chemo-immunosuppression
US4955857A (en) * 1988-07-18 1990-09-11 Shettigar Udipi R Multi-enzyme bioreactor therapy for cancer
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5227369A (en) * 1991-07-11 1993-07-13 The Regents Of The University Of California Compositions and methods for inhibiting leukocyte adhesion to cns myelin
US5466216A (en) * 1994-04-11 1995-11-14 Gish Biomedical, Inc. Antegrade/retrograde cardioplegia method and system
US6561996B1 (en) * 1998-05-19 2003-05-13 Transvivo, Inc. Apparatus and method for in vivo hemodialysis
US8197430B1 (en) 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
JP2002533169A (ja) * 1998-12-29 2002-10-08 オキュロジックス コーポレイション レオロジー的処置方法および関連するアフェレーシスシステム
CA2390095C (en) * 1999-11-10 2013-01-08 M. Rigdon Lentz Method and system to remove cytokine inhibitor in patients
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
WO2003012396A2 (en) * 2001-08-01 2003-02-13 Chauhan Anil K Immune complexes
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
US7101679B2 (en) 2003-11-25 2006-09-05 Mayo Foundation For Medical Education And Research Marker for neuromyelitis optica
JP2008511340A (ja) 2004-04-30 2008-04-17 バイオフェレシス テクノロジーズ， インコーポレイテッド 患者において可溶性ｔｎｆｒ１、可溶性ｔｎｆｒ２、および可溶性ｉｌ２を除去する方法およびシステム
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
WO2007089945A2 (en) * 2006-02-02 2007-08-09 The Trustees Of Columbia University In The City Of New York Treating diseases by targeting silt3
CA3061952C (en) 2006-03-09 2022-07-19 Aethlon Medical, Inc. Extracorporeal removal of microvesicular particles
US20080075690A1 (en) * 2006-09-22 2008-03-27 Mark Douglas Howell Method for enhancing immune responses in mammals
US8926543B2 (en) * 2009-10-08 2015-01-06 Otsuka Pharmaceutical Co., Ltd. Immunoactivation blood perfusion filter for the treatment of malignant tumors
US20160208011A1 (en) 2010-01-28 2016-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
US10626399B2 (en) 2010-01-28 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
US9161968B2 (en) 2011-04-08 2015-10-20 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
WO2012163544A1 (en) 2011-06-01 2012-12-06 Biopheresis Technologies, Inc. Removal of soluble tumor necrosis factor receptor 2 (stnfr2)
GR1007816B (el) 2011-10-17 2013-01-28 Σωκρατης Ιωαννη Τζαρτος Βιολογικος δεικτης
CA2865170C (en) 2012-02-21 2020-12-22 Cytonics Corporation Systems, compositions, and methods for transplantation
WO2013179143A2 (en) 2012-06-01 2013-12-05 Biopheresis Technologies, Inc. Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors
JP6667438B2 (ja) 2013-12-09 2020-03-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 老化に関連する状態を処置する方法及び組成物
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
ES2902467T3 (es) 2015-06-15 2022-03-28 Univ Leland Stanford Junior TIMP2 para su uso en el tratamiento de afecciones asociadas al envejecimiento
ES2975517T3 (es) 2016-04-28 2024-07-08 Alkahest Inc Fracciones de plasma como terapia para el cáncer de timo
US11061027B2 (en) 2016-09-27 2021-07-13 Mayo Foundation For Medical Education And Research Materials and methods for evaluating and treating cancer
EA039316B1 (ru) 2016-10-24 2022-01-12 Алкахест, Инк. Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением
US11040068B2 (en) 2017-04-26 2021-06-22 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
CN117899111A (zh) 2017-04-26 2024-04-19 万能溶剂有限公司 用血浆和血浆制品治疗认知障碍和运动障碍的给药方案
UA128648C2 (uk) 2018-10-26 2024-09-18 Алкахест, Інк. Застосування плазми крові та фракцій плазми для пом'якшення болю, поліпшення загоювання ран та післяопераційного відновлення
WO2020154654A1 (en) 2019-01-25 2020-07-30 Mayo Foundation For Medical Education And Research Assessing and treating germ cell tumors and paraneoplastic autoimmunity
WO2021211351A1 (en) 2020-04-12 2021-10-21 Aethlon Medical, Inc. Devices and methods for treating a coronavirus infection and symptoms thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31688A (en) * 1861-03-12 Method of locking type-g-alleys
US4116589A (en) * 1977-04-15 1978-09-26 Avco Corporation Extracorporeal pulsatile blood pump comprised of side by side bladders
USRE31688E (en) 1977-09-23 1984-09-25 Hemotherapy, Inc. Method and apparatus for continuous plasmapheresis
US4191182A (en) * 1977-09-23 1980-03-04 Hemotherapy Inc. Method and apparatus for continuous plasmaphersis
WO1979001121A1 (en) * 1978-05-25 1979-12-27 Department Of Commerce Process for separating blood cell-containing liquid suspensions by filtration
JPS5581657A (en) * 1978-12-14 1980-06-19 Senko Med Instr Mfg Purifying waterrremoving method of blood
NO144411C (no) * 1979-04-19 1981-08-26 Nycotron As Anordning for gradering av biologisk vaeslke, saerlig blod, etter molekylvekt.
JPS5692824A (en) * 1979-07-04 1981-07-27 Terumo Corp Eliminant of immunosuppressive substance in humors
US4384954A (en) * 1980-04-16 1983-05-24 Kuraray Co., Ltd. Column for adsorption of blood proteins
JPS56145859A (en) * 1980-04-16 1981-11-12 Kuraray Co Treating device for blood
JPS5756039A (en) * 1980-09-22 1982-04-03 Kuraray Co Ltd Adsorbent for middle molecular weight protein
US4350594A (en) * 1980-04-16 1982-09-21 Kuraray Co., Ltd. Blood purification using plural ultrafiltration stages
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
JPS583705B2 (ja) * 1980-07-18 1983-01-22 川澄化学工業株式会社 二重ロ過型血漿分離交換装置
JPS587256A (ja) * 1981-07-06 1983-01-17 テルモ株式会社 体液中の免疫抑制物質ｄｅｓ−ｉ除去剤
BR8205658A (pt) * 1981-10-02 1983-08-30 Du Pont Processo e aparelho de plasmaferese por filtracao
JPS5889273A (ja) * 1981-11-20 1983-05-27 株式会社クラレ 免疫反応促進材
JPS58173555A (ja) * 1982-04-05 1983-10-12 旭メデイカル株式会社 血液浄化装置
JPS58173556A (ja) * 1982-04-05 1983-10-12 旭メデイカル株式会社 血液浄化装置
JPS58185165A (ja) * 1982-04-26 1983-10-28 株式会社　早島 限外濾過・濾過透析型人工腎臓
JPS5911865A (ja) * 1982-07-10 1984-01-21 日機装株式会社 血液浄化装置
JPS5946969A (ja) * 1982-09-09 1984-03-16 旭メディカル株式会社 血漿浄化装置
DE3302384A1 (de) * 1983-01-25 1984-07-26 Michael J. Lysaght Plasmafilteraggregat zum abscheiden pathologischer plasmamolekuele
JPS59168843A (ja) * 1983-03-14 1984-09-22 ジエルマン　サイエンシスインコ−ポレ−テツド 血漿試料を採取する方法とそのためのフィルタ

Also Published As

Publication number Publication date
MX168132B (es) 1993-05-06
AU596567B2 (en) 1990-05-10
EP0184040B1 (de) 1993-04-14
DE3587266D1 (de) 1993-05-19
IL77062A0 (en) 1986-04-29
ZA858676B (en) 1986-07-30
DE3587266T2 (de) 1993-07-29
EP0184040A3 (en) 1988-03-09
AU4992985A (en) 1986-05-22
CA1262681A (en) 1989-11-07
US4708713A (en) 1987-11-24
EP0184040A2 (de) 1986-06-11
JPS61172563A (ja) 1986-08-04

Similar Documents

Publication Publication Date Title
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
US4664913B1 (de)
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
ATE59146T1 (de) Geraet zur bestrahlung von blutteilen.
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE3886254D1 (de) Apparat zur Behandlung von biologischen Proben und Behandlungsmethoden mit dem Apparat.
DE3767123D1 (de) Verfahren zur bestimmung des haematokrit aus vollblut sowie vorrichtung zur durchfuehrung des verfahrens.
DE3669328D1 (de) Verfahren und anlage zur serienmaessigen, verzugsarmen thermomechanischen behandlung von werkstuecken sowie anwendung des verfahrens.
EP0313378A3 (de) Methoden und Zusammensetzungen für vorübergehende Elimination von humoralen immunen Antikörpern
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE68910175D1 (de) Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut.
DE3875575D1 (de) Verfahren und vorrichtung und vorrichtung zur herstellung und behandlung von transfermembranen.
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
FI103577B1 (fi) Menetelmä, DNA ja mikro-organismi trombolyyttisen aineen valmistamiseksi
DE3885733D1 (de) Verfahren zur befreiung von zellgemischen und geweben von unerwünschten populationen.
DE3888443D1 (de) Verfahren zur Herstellung von Dihydrochinacridonen, Chinacridonen und Chinacridonchinonen.
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
ATE167628T1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
ATA118987A (de) Kominiertes verfahren zur termischen und chemischen behandlung von lignocellulosehaltiger biomasse und zur gewinnung von furfural
DE3761377D1 (de) Verfahren zur aufarbeitung von 2-merkaptobenzthiazol enthaltenden teeren.
DE3886755D1 (de) Verfahren zur behandlung von gefässkrankheiten.
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
DE3864615D1 (de) Verfahren und anordnung zur behandlung von bei verbrennung schadstoffe freisetzendem holz, bzw. holzkohle.
ATE108664T1 (de) Verfahren zur verhütung von gvhd.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee